Chao-Qiang Lai1, Laurence D Parnell1, Caren E Smith2, Tao Guo2, Sergi Sayols-Baixeras3,4,5, Stella Aslibekyan6, Hemant K Tiwari6, Marguerite R Irvin6, Carl Bender2, David Fei2, Bertha Hidalgo6, Paul N Hopkins7, Devin M Absher8, Michael A Province9, Roberto Elosua3,4, Donna K Arnett10, Jose M Ordovas2,11,12. 1. USDA Agricultural Research Service, Nutrition and Genomics Laboratory, JM-USDA Human Nutrition Research Center on Aging at Tufts University, Boston, MA, USA. 2. Nutrition and Genomics Laboratory, JM-USDA Human Nutrition Research Center on Aging at Tufts University, Boston, MA, USA. 3. Cardiovascular Epidemiology and Genetics Research Group, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Catalonia, Spain. 4. CIBER Cardiovascular Diseases (CIBERCV), Barcelona, Catalonia, Spain. 5. Molecular Epidemiology, Department of Medical Sciences, Uppsala Universitet, Uppsala, Sweden. 6. Department of Epidemiology, School of Public Health, University of Alabama, Birmingham, AL, USA. 7. Department of Cardiovascular Genetics, University of Utah, Salt Lake City, UT, USA. 8. Hudson Alpha Institute for Biotechnology, Huntsville, AL, USA. 9. Department of Genetics, Washington University School of Medicine, St Louis, MO, USA. 10. College of Public Health, University of Kentucky, Lexington, KY, USA. 11. IMDEA Food Institute, CEI UAM + CSIC, Madrid, Spain. 12. Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
Abstract
BACKGROUND: Epigenome-wide association studies identified the cg00574958 DNA methylation site at the carnitine palmitoyltransferase-1A (CPT1A) gene to be associated with reduced risk of metabolic diseases (hypertriglyceridemia, obesity, type 2 diabetes, hypertension, metabolic syndrome), but the mechanism underlying these associations is unknown. OBJECTIVES: We aimed to elucidate whether carbohydrate and fat intakes modulate cg00574958 methylation and the risk of metabolic diseases. METHODS: We examined associations between carbohydrate (CHO) and fat (FAT) intake, as percentages of total diet energy, and the CHO/FAT ratio with CPT1A-cg00574958, and the risk of metabolic diseases in 3 populations (Genetics of Lipid Lowering Drugs and Diet Network, n = 978; Framingham Heart Study, n = 2331; and REgistre GIroní del COR study, n = 645) while adjusting for confounding factors. To understand possible causal effects of dietary intake on the risk of metabolic diseases, we performed meta-analysis, CPT1A transcription analysis, and mediation analysis with CHO and FAT intakes as exposures and cg00574958 methylation as the mediator. RESULTS: We confirmed strong associations of cg00574958 methylation with metabolic phenotypes (BMI, triglyceride, glucose) and diseases in all 3 populations. Our results showed that CHO intake and CHO/FAT ratio were positively associated with cg00574958 methylation, whereas FAT intake was negatively correlated with cg00574958 methylation. Meta-analysis further confirmed this strong correlation, with β = 58.4 ± 7.27, P = 8.98 x 10-16 for CHO intake; β = -36.4 ± 5.95, P = 9.96 x 10-10 for FAT intake; and β = 3.30 ± 0.49, P = 1.48 x 10-11 for the CHO/FAT ratio. Furthermore, CPT1A mRNA expression was negatively associated with CHO intake, and positively associated with FAT intake, and metabolic phenotypes. Mediation analysis supports the hypothesis that CHO intake induces CPT1A methylation, hence reducing the risk of metabolic diseases, whereas FAT intake inhibits CPT1A methylation, thereby increasing the risk of metabolic diseases. CONCLUSIONS: Our results suggest that the proportion of total energy supplied by CHO and FAT can have a causal effect on the risk of metabolic diseases via the epigenetic status of CPT1A.Study registration at https://www.clinicaltrials.gov/: the Genetics of Lipid Lowering Drugs and Diet Network (GOLDN)-NCT01023750; and the Framingham Heart Study (FHS)-NCT00005121. Published by Oxford University Press on behalf of the American Society for Nutrition 2020.
BACKGROUND: Epigenome-wide association studies identified the cg00574958 DNA methylation site at the carnitine palmitoyltransferase-1A (CPT1A) gene to be associated with reduced risk of metabolic diseases (hypertriglyceridemia, obesity, type 2 diabetes, hypertension, metabolic syndrome), but the mechanism underlying these associations is unknown. OBJECTIVES: We aimed to elucidate whether carbohydrate and fat intakes modulate cg00574958 methylation and the risk of metabolic diseases. METHODS: We examined associations between carbohydrate (CHO) and fat (FAT) intake, as percentages of total diet energy, and the CHO/FAT ratio with CPT1A-cg00574958, and the risk of metabolic diseases in 3 populations (Genetics of Lipid Lowering Drugs and Diet Network, n = 978; Framingham Heart Study, n = 2331; and REgistre GIroní del COR study, n = 645) while adjusting for confounding factors. To understand possible causal effects of dietary intake on the risk of metabolic diseases, we performed meta-analysis, CPT1A transcription analysis, and mediation analysis with CHO and FAT intakes as exposures and cg00574958 methylation as the mediator. RESULTS: We confirmed strong associations of cg00574958 methylation with metabolic phenotypes (BMI, triglyceride, glucose) and diseases in all 3 populations. Our results showed that CHO intake and CHO/FAT ratio were positively associated with cg00574958 methylation, whereas FAT intake was negatively correlated with cg00574958 methylation. Meta-analysis further confirmed this strong correlation, with β = 58.4 ± 7.27, P = 8.98 x 10-16 for CHO intake; β = -36.4 ± 5.95, P = 9.96 x 10-10 for FAT intake; and β = 3.30 ± 0.49, P = 1.48 x 10-11 for the CHO/FAT ratio. Furthermore, CPT1A mRNA expression was negatively associated with CHO intake, and positively associated with FAT intake, and metabolic phenotypes. Mediation analysis supports the hypothesis that CHO intake induces CPT1A methylation, hence reducing the risk of metabolic diseases, whereas FAT intake inhibits CPT1A methylation, thereby increasing the risk of metabolic diseases. CONCLUSIONS: Our results suggest that the proportion of total energy supplied by CHO and FAT can have a causal effect on the risk of metabolic diseases via the epigenetic status of CPT1A.Study registration at https://www.clinicaltrials.gov/: the Genetics of Lipid Lowering Drugs and Diet Network (GOLDN)-NCT01023750; and the Framingham Heart Study (FHS)-NCT00005121. Published by Oxford University Press on behalf of the American Society for Nutrition 2020.
Authors: Roby Joehanes; Saixia Ying; Tianxiao Huan; Andrew D Johnson; Nalini Raghavachari; Richard Wang; Poching Liu; Kimberly A Woodhouse; Shurjo K Sen; Kahraman Tanriverdi; Paul Courchesne; Jane E Freedman; Christopher J O'Donnell; Daniel Levy; Peter J Munson Journal: Arterioscler Thromb Vasc Biol Date: 2013-03-28 Impact factor: 8.311
Authors: Dolores Corella; Donna K Arnett; Michael Y Tsai; Edmond K Kabagambe; James M Peacock; James E Hixson; Robert J Straka; Michael Province; Chao-Qiang Lai; Laurence D Parnell; Ingrid Borecki; Jose M Ordovas Journal: Clin Chem Date: 2007-04-19 Impact factor: 8.327
Authors: Joan D Fernández-Ballart; Josep Lluís Piñol; Itziar Zazpe; Dolores Corella; Paula Carrasco; Estefanía Toledo; Manuel Perez-Bauer; Miguel Angel Martínez-González; Jorge Salas-Salvadó; José M Martín-Moreno Journal: Br J Nutr Date: 2010-01-27 Impact factor: 3.718
Authors: Sara B Seidelmann; Brian Claggett; Susan Cheng; Mir Henglin; Amil Shah; Lyn M Steffen; Aaron R Folsom; Eric B Rimm; Walter C Willett; Scott D Solomon Journal: Lancet Public Health Date: 2018-08-17
Authors: Ruth Pidsley; Chloe C Y Wong; Manuela Volta; Katie Lunnon; Jonathan Mill; Leonard C Schalkwyk Journal: BMC Genomics Date: 2013-05-01 Impact factor: 3.969
Authors: Jacob K Kresovich; Yong-Moon Mark Park; Jean A Keller; Dale P Sandler; Jack A Taylor Journal: Am J Clin Nutr Date: 2022-01-11 Impact factor: 8.472
Authors: Marguerite R Irvin; May E Montasser; Tobias Kind; Sili Fan; Dinesh K Barupal; Amit Patki; Rikki M Tanner; Nicole D Armstrong; Kathleen A Ryan; Steven A Claas; Jeffrey R O'Connell; Hemant K Tiwari; Donna K Arnett Journal: Nutrients Date: 2021-11-10 Impact factor: 5.717
Authors: Yu-Chi Lee; Jacob J Christensen; Laurence D Parnell; Caren E Smith; Jonathan Shao; Nicola M McKeown; José M Ordovás; Chao-Qiang Lai Journal: Front Genet Date: 2022-01-03 Impact factor: 4.599